Abstract
BackgroundBispecific antibodies redirecting T cells to the tumor obtain increasing interest as potential cancer immunotherapy. ERY974, a full-length bispecific antibody targeting CD3ε on T cells and glypican 3 (GPC3) on...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have